Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Tetra Bio-Pharma receives US FDA clearance on IND for QIXLEEF, setting the stage for clinical trial

% of readers think this story is Fact. Add your two cents.


Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) (FRA:JAM1) announced Friday that the US Food and Drug Administration (FDA) had cleared its investigational new drug application on its cancer painkiller QIXLEEF.  

The approval means that the Ottawa-based company can now start a 10-week clinical trial in cancer patients with breakthrough pain.

QIXLEEF has a ‘fixed ratio’ of THC and CBD and is inhaled through a vaporizer. It is squarely aimed at providing respite to advanced cancer patients with inadequately controlled pain. 

READ: Tetra Bio-Pharma to raise C$1.9M via a non-brokered private placement

The trial, titled Reborn1, is an open-label randomized study evaluating the effectiveness of inhaled QIXLEEF compared to morphine sulfate immediate release (MSIR) to treat cancer patients, who experience breakthrough pain – a sharp, intense pain episode. 

Reborn1’s endpoint is the time-weighted sum of pain intensity differences (SPID) from pre-dose to 30 minutes after being treated with QIXLEEF or MSIR. Patients will evaluate their pain levels for each episode. In addition, secondary endpoints include difference in pain intensity and onset of pain relief at 5, 10, 15, 30 and 60 minutes, which will give insight to the timing of the onset of symptom relief for both treatments.

The study design includes a screening and titration period of up to two weeks, followed by an open-label crossover comparison study, where each patient will receive the investigational drug and active comparator for a seven-week treatment period, during which the groups will switch treatments in the third week.

Commenting on the FDA approval, Tetra CEO Guy Chamberland told shareholders: “This is really good news for all of us and in particular for the cancer patients that suffer from breakthrough pain. We aim to initiate this proof-of-concept trial designed to demonstrate that QIXLEEF can provide pain relief faster than an immediate-release oral morphine.”

QIXLEEF will round up its Phase II trial in 2021 and its Phase III trial in early 2022. Tetra plans to submit a New Drug Application by 2022 and launch the drug by late 2023.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Story by ProactiveInvestors



Source: http://www.proactiveinvestors.com/companies/news/939881/tetra-bio-pharma-receives-us-fda-clearance-on-ind-for-qixleef-setting-the-stage-for-clinical-trial-939881.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse
Loading...

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.